SGLT2 inhibition during the COVID-19 epidemic: Friend or foe? Published on 2020-10-012023-07-05 Journal: Diabetes & metabolism [키워드] Adipose tissue COVID-19 Inflammation ketoacidosis SGLT2 inhibitor. [저자] A J Scheen [Category] SARS, PMC URL Pubmed URL [DOI] 10.1016/j.diabet.2020.06.003 [Article Type] Editorial [Source] pubmed All Keywords 【저자키워드】 COVID-19, Inflammation, Adipose tissue, ketoacidosis, SGLT2 inhibitor.,